Anavar 20 mg (Oxandrolone)
Anavar 20 mg (Oxandrolone) is a research-grade oral compound engineered for high-purity laboratory applications. Each bottle contains 50 HPLC-verified tablets, third-party tested to guarantee over 99% purity and manufactured under strict quality standards in the USA. Formulated specifically for analytical study into androgen receptor dynamics, lean tissue preservation, and nitrogen retention models, this product is strictly intended for research use only.
AOD 9604 (5mg)
AOD 9604 5mg is a premium, high-purity (\ge99% HPLC-verified) synthetic analog of the C-terminal region of human growth hormone (hGH 177-191). Engineered specifically to isolate lipolytic receptor activity without elevating IGF-1 levels or altering glucose metabolism, AOD 9604 is an essential tool for laboratory studies targeting lipid metabolism, adipocyte signaling, and cartilage matrix regeneration. Supplied as a sterile lyophilized powder strictly for scientific research use.
ARA-290 Peptide (16mg)
ARA-290 16 mg provides a high-purity, laboratory-verified lyophilized peptide manufactured under strict quality control standards in the USA. Formulated with 16 mg of pure ARA-290 (Cibinetide; Pyroglu-Glu-Gln-Glu-Arg-Glu-Arg-Ala-Glu-Ala-Lys-Glu)āa 11-amino-acid synthetic peptide derived from the erythropoietin (EPO) structureāthis compound selectively targets the Innate Repair Receptor (IRR) without stimulating erythropoiesis. It is widely utilized in neurology, immunology, and tissue regeneration research investigating neuropathic pain attenuation, small nerve fiber regeneration, and inflammatory cytokine suppression.
Key Specifications
Active Compound: ARA-290 (Cibinetide / Pyroglutamate Helix B Surface Peptide)
Chemical Formula: \text{C}_{51}\text{H}_{84}\text{N}_{16}\text{O}_{21}
Concentration: 16 mg per vial
Purity Standard: Exceeds 99% (Third-Party HPLC Verified)
Formulation: Sterile Lyophilized Powder
Origin: Manufactured in USA
Classification: Research Use Only
Primary Research Applications
Selective Innate Repair Receptor (IRR) Activation: ARA-290 selectively binds the erythropoietin receptor / \beta-common receptor (\text{EPOR/}\beta\text{cR}) heterodimer to initiate anti-inflammatory and tissue-protective signaling without increasing red blood cell count or hematocrit levels.
Small Fiber Neuropathy & Peripheral Nerve Repair: Extensively studied in neuropathic disease models for its ability to promote small nerve fiber density restoration, repair damaged peripheral axons, and relieve neuropathic pain signaling.
Anti-Inflammatory & Ischemic Protection: Investigated for its inhibitory effects on pro-inflammatory cytokine cascades (\text{TNF-}\alpha, \text{IL-6}) and its protective role against ischemia-reperfusion injury in cardiovascular and metabolic tissue models.
Arimidex 1 mg (Anastrozole)
Arimidex 1 mg (Anastrozole) is a research-grade oral compound engineered for high-purity laboratory applications. Each bottle contains 50 HPLC-verified tablets, third-party tested to guarantee over 99% purity and manufactured in the USA under strict laboratory standards. Formulated specifically for research investigating aromatase (CYP19) enzyme inhibition, estrogen synthesis suppression, and receptor-mediated signaling pathways, this product is strictly intended for research use only.
Aromasin 10 mg (Exemestane Tablets)
Aromasin 10 mg (Exemestane) is a research-grade oral compound engineered for high-purity laboratory applications. Each bottle contains 50 HPLC-verified tablets, third-party tested to guarantee over 99% purity and manufactured in the USA under strict standards. Formulated specifically for research investigating irreversible (suicide) aromatase inhibition, estrogen biosyntheses suppression, and endocrine pathways, this product is strictly intended for research use only.
B7-33 (6mg)
B7-33 6 mg provides a high-purity, laboratory-verified lyophilized peptide manufactured under strict quality control standards in the USA. Formulated with 6 mg of pure B7-33āa single-chain synthetic peptide functional analog of human gene-2 relaxin (H2 relaxin)āthis compound is widely utilized in cardiovascular, nephrology, and matrix biology research examining selective RXFP1 receptor signaling, extracellular matrix (ECM) remodeling, and anti-fibrotic signaling pathways without inducing tumor growth pathways.
Key Specifications
Active Compound: B7-33 (Relaxin-2 Receptor Agonist)
Chemical Formula: \text{C}_{136}\text{H}_{210}\text{N}_{40}\text{O}_{41}
Concentration: 6 mg per vial
Purity Standard: Exceeds 99% (Third-Party HPLC Verified)
Formulation: Sterile Lyophilized Powder
Origin: Manufactured in USA
Classification: Research Use Only
Primary Research Applications
Targeted Anti-Fibrotic Activity: B7-33 acts through the RXFP1 receptor to upregulate matrix metalloproteinases (MMPs) and suppress excessive collagen deposition, providing a targeted model for reversal of organ fibrosis.
Cardiovascular & Renal Remodeling: Extensively evaluated in preclinical models of heart failure, renal scarring, and vascular stiffness to assess hemodynamic regulation and arterial compliance enhancement.
Biasing RXFP1 Receptor Signaling: Investigated for its ability to preferentially stimulate pERK signaling over cAMP accumulation, preventing unwanted inotropic or proliferative side effects associated with full-length native relaxin.
BPC-157 (10 mg)
BPC-157 (10mg) is a high-purity (ā„98%) research-grade pentadecapeptide extensively studied for its powerful tissue regeneration, tendon healing, and gut mucosa protective properties. Supplied as a stable lyophilized powder, every batch undergoes strict HPLC and Mass Spectrometry testing to guarantee maximum purity and reliable research results.
For research and laboratory use only. Not for human consumption.
BPC-157 & TB-500 & GHK-Cu Blend (70mg)
BPC-157 / TB-500 / GHK-Cu provides a high-purity, laboratory-verified lyophilized multi-peptide blend manufactured under strict quality control standards in the USA. Formulated as an advanced triple-action tissue regeneration complex, each vial combines 10 mg of BPC-157 (Body Protection Compound-157), 10 mg of TB-500 (Thymosin Beta-4 fragment), and 50 mg of GHK-Cu (Copper Tripeptide-1). This synergistic 70 mg total blend is widely utilized in orthopedic, dermatological, and cellular repair research examining angiogenesis, actin sequestration, collagen remodeling, and wound healing cascades.
Key Specifications
Ā Active Compounds: BPC-157 (Pentadecapeptide), TB-500 (Thymosin Beta-4 Fragment), & GHK-Cu (Copper Tripeptide-1)
Ā Blend Concentration: 10 mg BPC-157 + 10 mg TB-500 + 50 mg GHK-Cu (70 mg total per vial)
Ā Chemical Formulas: \text{C}_{62}\text{H}_{98}\text{N}_{16}\text{O}_{22} (BPC-157) / \text{C}_{212}\text{H}_{350}\text{N}_{56}\text{O}_{78}\text{S} (TB-500) / \text{C}_{14}\text{H}_{24}\text{CuN}_{6}\text{O}_{4} (GHK-Cu)
Ā Purity Standard: Exceeds 99% (Third-Party HPLC Verified)
Ā Formulation: Sterile Lyophilized Powder
Ā Origin: Manufactured in USA
Ā Classification: Research Use Only
Primary Research Applications
Ā Synergistic Angiogenesis & Microvascular Repair: Combines BPC-157's VEGFR2 pathway modulation with TB-500's cell migration properties to evaluate accelerated capillary outgrowth and blood vessel formation in damaged tissues.
Ā Extracellular Matrix & Collagen Synthesis: GHK-Cu works in tandem with BPC-157 and TB-500 to stimulate Type I and III collagen expression, dermal fibroblast activation, and glycosaminoglycan production.
Ā Musculoskeletal Tissue Regeneration: Extensively studied in tendon, ligament, muscle, and fascial injury models to measure actin regulation, cell migration to damage sites, and reduced inflammatory scarring.
BPC-157 & TB-500 Blend 20mg
BPC-157 / TB-500 20mg provides a high-purity, laboratory-verified lyophilized peptide blend manufactured under strict quality control standards in the USA. Formulated as a synergistic tissue recovery complex, each vial combines BPC-157 (Body Protection Compound-157, a synthetic pentadecapeptide) with TB-500 (Thymosin Beta-4 synthetic fragment). This dual-action blend is widely utilized in orthopedic, gastrointestinal, and cellular repair research examining accelerated wound healing cascades, microvascular formation, actin regulation, and connective tissue remodeling.
Key Specifications
Ā Active Compounds: BPC-157 (Pentadecapeptide) & TB-500 (Thymosin Beta-4 Fragment)
Ā Chemical Formulas: \text{C}_{62}\text{H}_{98}\text{N}_{16}\text{O}_{22} (BPC-157) / \text{C}_{212}\text{H}_{350}\text{N}_{56}\text{O}_{78}\text{S} (TB-500)
Ā Purity Standard: Exceeds 99% (Third-Party HPLC Verified)
Ā Formulation: Sterile Lyophilized Powder
Ā Origin: Manufactured in USA
Ā Classification: Research Use Only
Primary Research Applications
Ā Angiogenesis & Microvascular Upregulation: Combines BPC-157's VEGFR2 pathway upregulation with TB-500's endothelial cell migration properties to study rapid blood vessel formation in damaged tissues.
Ā Actin Polymerization & Cell Mobility: TB-500 sequestering of G-actin works alongside BPC-157 to examine accelerated cell migration, tendon-to-bone insertion recovery, and fascial repair.
Ā Cytoprotection & Inflammation Modulation: Evaluated in cellular stress models to investigate the downregulation of pro-inflammatory cytokines and stabilization of mucosal and musculoskeletal matrices.